Form 8.3 - Horizon Therapeutics plc

LONDON--()-- 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)

Millennium International Management LP

Company dealt in

Horizon Therapeutics plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

IE00BQPVQZ61

Date of dealing

16th May 2023

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

4,856,244

(2.123%)

2,316

(0.001%)

(2) Derivatives (other than options)

-

-

(3) Options and agreements to purchase/sell

466,200

(0.204%)

1,434,100

(0.627%)

Total

5,322,444

(2.327%)

1,436,416

(0.628%)

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (USD) (Note 5)

Purchase

215

91.37

Sale

43

95.19

Sale

600

95.19

Sale

210

95.00

Sale

25,900

95.33

Sale

690

95.28

Sale

1,900

95.24

Sale

500

95.29

Sale

100

95.26

Sale

100

95.32

Sale

200

96.34

Sale

1,213

95.57

Sale

15,561

95.50

Sale

1,010

95.58

Sale

100

95.59

Sale

75

94.78

Sale

528

95.51

Purchase

33

95.13

Sale

200

95.53

Sale

100

95.56

Sale

1,200

95.55

Purchase

1

95.30

Purchase

1,000

95.43

Sale

3,326

96.08

Purchase

484

96.77

Sale

100

96.80

Sale

1,000

95.54

Sale

100

95.60

Sale

50

94.32

Sale

2,791

96.20

Sale

3,042

96.00

Sale

75

94.56

Sale

985

96.47

Sale

320

95.52

Sale

6,478

96.01

Sale

400

96.02

Sale

400

96.42

Sale

3,117

96.13

Sale

1,100

96.06

Purchase

100

96.64

Sale

1,700

96.48

Sale

2,942

96.05

Purchase

5

95.73

Purchase

1,794

96.51

Sale

1,200

96.55

Sale

3,100

96.07

Sale

300

96.54

Purchase

44

95.85

Sale

27,749

96.23

Sale

3,405

96.29

Sale

600

96.28

Sale

200

96.36

Purchase

22

96.30

Sale

2,490

96.10

Purchase

100

96.82

Sale

1,000

96.18

Sale

2,200

96.03

Purchase

9,630

96.34

Sale

100

93.00

Sale

100

94.82

Sale

200

95.21

Sale

100

91.59

Sale

100

92.24

Sale

100

95.38

Sale

100

91.67

Sale

227

91.33

Sale

100

95.08

Sale

100

91.02

Sale

33

95.13

Sale

100

91.95

Sale

300

95.04

Sale

100

95.30

Sale

1,000

95.43

Sale

100

92.94

Sale

1,100

95.00

Sale

300

93.44

Sale

1

95.80

Sale

100

95.34

Sale

100

94.54

Sale

1,273

93.65

Sale

100

92.73

Sale

100

95.20

Sale

1,000

95.45

Sale

300

95.27

Sale

3,476

95.14

Sale

100

96.62

Sale

200

95.05

Sale

400

95.06

Sale

100

95.79

Sale

100

94.97

Sale

651

96.44

Sale

200

95.29

Sale

182

94.87

Sale

200

95.26

Sale

100

94.75

Sale

100

94.40

Sale

100

94.53

Sale

249

96.04

Sale

5,009

95.71

Sale

400

94.84

Sale

200

94.79

Sale

44

95.85

Sale

99

96.21

Sale

103

94.46

Sale

197

94.58

Sale

512

94.55

Sale

200

94.57

Sale

340

94.54

Sale

64

94.52

Sale

900

94.51

Sale

25,000

93.01

Sale

11,581

92.38

Purchase

1,153

96.34

Sale

200

91.44

Sale

10,000

91.60

Sale

10,200

93.00

Sale

400

92.68

Sale

380

95.21

Purchase

3,988

95.57

Sale

26

91.37

Purchase

790

92.09

Sale

583

92.09

Purchase

5,280

93.50

Sale

2,000

93.50

Purchase

18,897

92.51

Purchase

101

91.36

Sale

1,200

92.92

Sale

1,051

91.75

Purchase

257

91.76

Purchase

2,744

91.99

Purchase

739

91.34

Purchase

150

95.50

Sale

252

91.54

Sale

5

91.90

Sale

26

91.18

Sale

5,112

92.83

Purchase

100

93.49

Purchase

10

92.50

Sale

5,237

92.50

Sale

3,312

95.38

Purchase

5,800

93.16

Purchase

1,000

91.33

Sale

100

91.33

Sale

200

91.32

Sale

11,900

92.16

Purchase

160

92.08

Sale

800

92.08

Purchase

1,593

92.53

Sale

4,550

92.07

Purchase

460

91.31

Sale

1,779

91.84

Sale

600

95.08

Sale

113

91.27

Purchase

3,743

91.53

Sale

300

91.17

Sale

200

91.28

Purchase

100

94.99

Sale

855

94.99

Sale

325

95.10

Sale

29

95.13

Purchase

500

91.50

Sale

9,399

91.50

Sale

400

94.46

Sale

1,782

91.13

Purchase

1,550

91.83

Purchase

2,958

91.95

Sale

200

91.82

Purchase

6,350

92.10

Purchase

200

91.55

Sale

8,800

92.90

Purchase

1,366

92.00

Sale

28,217

92.00

Sale

100

94.30

Sale

1,582

95.07

Sale

2,921

91.61

Sale

6,222

95.55

Sale

700

93.79

Sale

500

91.52

Sale

1,293

95.03

Sale

1,100

94.18

Sale

200

94.21

Purchase

1,536

95.04

Sale

242

95.04

Sale

6,574

95.30

Purchase

100

92.06

Purchase

1,230

95.43

Purchase

2,990

92.25

Sale

5,122

91.85

Purchase

750

91.65

Sale

3,100

91.65

Purchase

16,851

93.58

Purchase

2,376

95.40

Sale

1,777

95.00

Sale

2,000

96.80

Sale

911

94.80

Sale

287

94.61

Sale

100

94.90

Sale

400

91.49

Purchase

500

94.57

Sale

1,036

94.57

Purchase

100

95.02

Sale

400

95.02

Sale

65

91.48

Sale

1,743

95.18

Sale

122

94.69

Sale

3,500

94.32

Sale

160

95.39

Sale

1,200

94.54

Purchase

300

93.41

Purchase

400

93.48

Sale

145

95.01

Sale

400

96.00

Sale

193

95.20

Purchase

300

95.45

Sale

110

95.27

Purchase

100

95.63

Purchase

2,243

95.48

Sale

6,048

95.48

Purchase

100

95.67

Sale

391

95.28

Purchase

12,762

94.60

Sale

201

94.60

Sale

1,112

95.14

Purchase

100

96.45

Purchase

5,000

95.05

Sale

100

95.05

Purchase

3,845

96.25

Purchase

100

95.66

Sale

861

95.66

Sale

3,000

96.47

Sale

225

95.52

Sale

625

92.88

Purchase

1,087

95.25

Sale

1,047

95.25

Sale

1,445

95.24

Sale

1,000

96.88

Purchase

20

93.46

Sale

13

91.03

Sale

82

92.99

Sale

14,734

94.97

Purchase

751

96.44

Sale

500

94.95

Sale

288

94.68

Purchase

272

95.29

Sale

2,858

91.69

Purchase

3,623

93.43

Purchase

11,577

94.62

Sale

200

95.35

Purchase

200

96.46

Purchase

4,649

95.47

Purchase

409

93.24

Sale

200

94.81

Sale

2,910

96.02

Purchase

400

96.42

Purchase

100

95.37

Purchase

5,545

94.67

Purchase

790

94.87

Purchase

1,963

95.46

Purchase

600

95.49

Purchase

3,337

95.26

Sale

710

95.26

Purchase

100

96.50

Sale

1,900

96.50

Sale

650

96.06

Purchase

100

96.48

Purchase

2,919

96.69

Sale

400

96.05

Purchase

600

96.51

Purchase

700

95.93

Sale

3,291

95.93

Sale

190

95.44

Purchase

227

95.91

Sale

659

95.91

Purchase

2,909

94.98

Purchase

600

95.87

Purchase

601

96.40

Sale

1,376

95.11

Purchase

870

93.89

Purchase

700

95.42

Purchase

2,785

94.08

Purchase

1,560

94.59

Purchase

3,225

95.15

Sale

275

94.89

Purchase

5,424

94.10

Purchase

1,200

91.86

Sale

2,000

96.67

Purchase

6,342

93.13

Purchase

5,009

95.71

Purchase

200

96.52

Purchase

755

94.35

Sale

1,535

95.77

Purchase

600

96.54

Purchase

100

96.15

Purchase

799

93.33

Purchase

1,000

95.84

Purchase

100

93.82

Purchase

100

96.35

Purchase

16

96.63

Purchase

3,871

96.30

Purchase

632

96.27

Purchase

4,346

96.24

Sale

1,141

96.11

Purchase

777

94.77

Purchase

342

96.58

Purchase

100

96.49

Sale

900

95.16

Sale

2,900

95.72

Sale

200

95.96

Purchase

7

94.82

Purchase

1

95.21

Purchase

1

92.98

Purchase

5

92.69

Purchase

3

92.34

Purchase

1

90.65

Purchase

1

95.38

Purchase

2

93.88

Purchase

1

95.13

Purchase

5

94.47

Purchase

1

95.41

Purchase

2

94.58

Purchase

1

95.18

Purchase

3

95.45

Purchase

1

93.05

Purchase

3

94.83

Purchase

4

95.67

Purchase

1

96.65

Purchase

1

96.50

Purchase

1

95.91

Purchase

3

95.64

Purchase

1

96.27

Purchase

1

96.10

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit (USD)

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

(USD)

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

Put Option

Selling

233,100

100.00

American

5/19/2023

 

Put Option

Selling

51,900

100.00

American

6/16/2023

 

Call Option

Purchasing

25,000

110.00

American

5/19/2023

 

Put Option

Selling

4,900

110.00

American

5/19/2023

 

Put Option

Purchasing

200,000

80.00

American

8/18/2023

 

Put Option

Selling

200,000

100.00

American

8/18/2023

 

Put Option

Selling

25,000

105.00

American

5/19/2023

 

Put Option

Purchasing

237,600

85.00

American

6/16/2023

 

Put Option

Purchasing

50,000

95.00

American

6/16/2023

 

Put Option

Selling

250,000

70.00

American

1/19/2024

 

Put Option

Purchasing

250,000

85.00

American

1/19/2024

 

Put Option

Purchasing

50,000

90.00

American

6/16/2023

 

Put Option

Purchasing

50,000

90.00

American

7/21/2023

 

Call Option

Purchasing

35,000

95.00

American

5/19/2023

 

Call Option

Purchasing

25,000

100.00

American

5/19/2023

 

Call Option

Purchasing

50,000

100.00

American

6/16/2023

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None.

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure

17th May 2023

Contact name

Stephen Glasper

Telephone number

+44 203 398 2166

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

Ap32

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1. KEY INFORMATION

Full name of person making
disclosure:

Millennium International Management LP

Name of offeror/offeree in relation
to whose relevant securities the
disclosure relates:

Horizon Therapeutics plc

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of
relevant
security

Product
description
e.g. call
option

Written or
purchased

Number of
securities to
which option
or derivative
relates

Exercise
price
per unit

(USD)

Type
e.g.
American,
European
etc.

Expiry
date

IE00BQPVQZ61

Put Option

Purchased

1,100

90.00

American

5/19/2023

IE00BQPVQZ61

Call Option

Purchased

11,500

110.00

American

5/19/2023

IE00BQPVQZ61

Call Option

Written

241,900

115.00

American

5/19/2023

IE00BQPVQZ61

Call Option

Purchased

42,500

120.00

American

5/19/2023

IE00BQPVQZ61

Put Option

Purchased

14,800

110.00

American

5/19/2023

IE00BQPVQZ61

Put Option

Purchased

2,900

80.00

American

5/19/2023

IE00BQPVQZ61

Put Option

Purchased

300

80.00

American

1/17/2025

IE00BQPVQZ61

Put Option

Purchased

300

90.00

American

1/19/2024

IE00BQPVQZ61

Call Option

Purchased

1,200

110.00

American

8/18/2023

IE00BQPVQZ61

Call Option

Written

201,200

115.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Written

50,000

80.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Purchased

29,000

80.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Purchased

11,300

100.00

American

5/19/2023

IE00BQPVQZ61

Put Option

Purchased

3,600

105.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

10,900

105.00

American

7/21/2023

IE00BQPVQZ61

Call Option

Written

100,000

115.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

284,200

85.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

118,100

100.00

American

6/16/2023

IE00BQPVQZ61

Call Option

Purchased

300

110.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

300

110.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

53,500

95.00

American

6/16/2023

IE00BQPVQZ61

Call Option

Written

300

110.00

American

7/21/2023

IE00BQPVQZ61

Put Option

Written

300

110.00

American

7/21/2023

IE00BQPVQZ61

Put Option

Written

400

110.00

American

8/18/2023

IE00BQPVQZ61

Call Option

Written

400

110.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Purchased

10,000

105.00

American

5/19/2023

IE00BQPVQZ61

Put Option

Written

250,000

70.00

American

1/19/2024

IE00BQPVQZ61

Put Option

Purchased

250,000

85.00

American

1/19/2024

IE00BQPVQZ61

Put Option

Purchased

50,000

90.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

50,000

90.00

American

7/21/2023

IE00BQPVQZ61

Call Option

Purchased

35,000

95.00

American

5/19/2023

IE00BQPVQZ61

Call Option

Purchased

25,000

100.00

American

5/19/2023

IE00BQPVQZ61

Call Option

Purchased

50,000

100.00

American

6/16/2023

3. AGREEMENTS TO PURCHASE OR SELL

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

 

Ap33

4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS’ AND OTHER EMPLOYEE OPTIONS)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

Category Code: RET
Sequence Number: 1100009
Time of Receipt (offset from UTC): 20230517T153358+0100

Contacts

Millennium Partners, L.P.

Contacts

Millennium Partners, L.P.